Seong Jae Kang

4PUBLICATIONS
22CO-AUTHORS
Molecular targetsSignal processingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 23, 2023
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.

Crismita Dmello, Junfei Zhao, Li Chen

|Mar 20, 2023
Split-tracrRNA as an efficient tracrRNA system with an improved potential of scalability.

Jihyun Park, Seong Jae Kang, Seulgi Go

|Jul 12, 2022
EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms.

Moon Jung Choi, Kang Chan Choi, Do Hyun Lee

|May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.

Crismita Dmello, Aarón Sonabend, Victor A Arrieta

Pageof 1

Frequent Collaborators

2 joint publications

Crismita Dmello

2 joint publications

Daniel Y Zhang

2 joint publications

Adam M Sonabend

1 joint publications

Aarón Sonabend